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SNF1as(I132G)Snf1, the yeast AMP-activated kinase homolog, regulates the expression of several genes involved in adaptation
to glucose limitation and in response to cellular stresses. We previously demonstrated that Snf1 interacts with
Swi6, the regulatory subunit of SBF and MBF complexes, and activates CLB5 transcription. Here we report that,
in α-factor synchronized cells in 2% glucose, the loss of the Snf1 catalytic subunit impairs the binding of SBF
and MBF complexes and the subsequent recruitment of the FACT complex and RNA Polymerase II to promoters
of G1-genes. By using an analog-sensitive allele of SNF1, SNF1as(I132G), encoding a protein whose catalytic activ-
ity is selectively inhibited in vivo by 2-naphthylmethyl pyrazolopyrimidine 1, we show that the inhibition of Snf1
catalytic activity affects the expression of G1-genes causing a delayed entrance into S phase in cells synchronized
in G1 phase by α-factor treatment or by elutriation. Moreover, Snf1 is detected in immune complexes of Rpb1,
the large subunit of RNA Polymerase II, and is present at both promoters and coding regions of SBF- and MBF-
regulated genes 20 min after α-factor release, suggesting a direct role for Snf1 in the activation of the G1-
regulon transcription.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The AMP-activated protein kinase (AMPK) family is constituted by
Serine/Threonine protein kinases that are highly conserved in eukary-
otes, from yeast and insects to plants and mammals. Their primary
role is the integration of signals from nutrient availability and environ-
mental stresses, to ensure the adaptation to those conditions and cell
survival [1,2]. Like its homolog AMPK, the Saccharomyces cerevisiae
Snf1 exists as a heterotrimeric complexmade by the catalyticα subunit
and the regulatory β and γ subunits [3,4]. The catalytic α subunit
(encoded by SNF1 gene) is activated by the phosphorylation of a T-
loop threonine residue (Thr210) by one of the upstream kinases Sak1,
Tos3 or Elm1 [5,6]. Snf1 activation also requires its interaction with
the γ subunit Snf4, which stabilizes the active conformation of the ki-
nase [7,8]. The interaction with one of the three alternative β subunits
(encoded by either SIP1, SIP2 or GAL83 genes) determines thetems Biology, Department of
-Bicocca, Italy. Tel.: +39 02
hina), paola.coccetti@unimib.it
-IEO Campus, via Adamello 16,
ights reserved.intracellular localization of Snf1 complex, targeting the kinase to specif-
ic substrates [9–11].
Snf1 upstream kinases are constitutively active, but metabolic sig-
nals, such as high glucose concentrations, regulate the protein phospha-
tase 1 complex (PP1) Reg1/Glc7, which dephosphorylates and hence
inactivates Snf1 [12]. PP2A-type phosphatases have also been involved
in regulating Snf1 activity [13,14]. The activation of Snf1 is ﬁnely regu-
lated and variousmutants have been reported to severely affect Snf1 ki-
nase activity [15–20].
Although Snf1 is not allosterically activated by AMP as AMPK is [21],
its activation is inﬂuenced by ADP which binds the γ subunit Snf4 and
regulates the Reg1/Glc7 complex preventing Snf1 dephosphorylation
[22,23].
Besides its well known role in metabolism, stress response and reg-
ulation of transcriptional activity of the histone acetyltransferase Gcn5
[4,24,25], a new function for Snf1 in the regulation of the G1/S phase
transition of the cell cycle has been reported [26]. During this transition
severalmetabolic and environmental signals are integrated and S-phase
entrance requires a burst of transcription of about 200 genes (G1-
regulon) [27–32], which is mediated by the transcription factors SBF
and MBF. Both are heterodimers composed of a common regulatory
subunit, Swi6, and two DNA-binding proteins, Swi4 in SBF and Mbp1
in MBF. SBF complex regulates transcription of genes involved in bud
emergence and spindle pole body duplication, among which CLN1,
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replication, repair and metabolism such as CLB5, CLB6 and RNR1 [33].
Although each factor controls a speciﬁc set of genes, a considerable
functional overlap between SBF and MBF is reported [27,34–38].
SBF and MBF complexes play a major role in the control of G1 tran-
scription [27,39–41] together with the chromatin remodeling complex
FACT (FAcilitating Chromatin Transcription) and the Srb/mediator com-
plex [42–47]. Activation of Cdk1/Cln and Pho85/Pcl complexes, by re-
lieving Whi5 inhibition, allows the recruitment of RNA Polymerase II
(RNA Pol II) and several other general transcription factors [29,48–50],
which ultimately lead to the formation of a complete pre-initiation
complex (PIC) at G1-genes [45,46,51,52].
In this study we have identiﬁed a new role for Snf1, revealing a pre-
viously unrecognizedmode of regulation for G1-speciﬁc transcription in
2% glucose condition, which depends on its catalytic activity.2. Materials and methods
2.1. Yeast strains and growth conditions
S. cerevisiae strains used in this study are listed in Table 1. Standard
genetic methods were used for strain construction. Synthetic medium
contained 2% glucose, 6.7 g/L of Yeast Nitrogen Base (Difco), 100–
50 mg/L of required nutrients, at standard pH (5.5). Cell density of liq-
uid cultures grown at 30 °C was determined with a Coulter counter
on mildly sonicated and diluted samples. For G1 synchronization,
cells were grown to exponential phase and α-factor (GenScript) was
added to a ﬁnal concentration of 3 μM. For experiments with the
SNF1(I132G)as strain, 25 μM 2NM-PP1 (from a 25 mM stock in 100%
DMSO)was added 1 h before the release fromα-factor to inhibit the ac-
tivity of Snf1 [53] and 25 μM 2NM-PP1 was also added in the release
medium. As a control, a culture grown in the presence of the same con-
centration of solvent (0.1% DMSO) was used.
Elutriations were performed essentially as in [54], using a 40 ml
chamber elutriator (Beckman Coulter, Milan, Italy). Percentage of bud-
ded cells was determined by direct microscopic counting of at least
300 cells after mild sonication.Table 1
Yeast strains used in this study.
Strain Genotype Source
Wt MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 Open Biosystems
snf1Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
snf1::KAN
[26]
SNF1-myc MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
SNF1-9myc:URA3
[26]
SNF1-myc mbp1Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0,
mbp1::kanMX4 SNF1-9myc:URA3
This study
SNF1-myc swi4Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0,
swi4::kanMX4 SNF1-9myc:URA3
This study
SNF1-myc swi6Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0,
swi6::kanMX4 SNF1-9myc:URA3
This study
SWI4-myc MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
SWI4-9myc:HPH
This study
SWI4-myc snf1Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
SWI4-9myc:HPH snf1::KAN
This study
MBP1-HA MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
MBP1-4HA:URA3
This study
MBP1-HA snf1Δ MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
MBP1-4HA:URA3 snf1::HPH
This study
SNF1as MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
snf1::KAN [pSNF1-I132G-3HA (URA3)]
This study
SNF1-HA MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
snf1::KAN [pSNF1-3HA (URA3)]
[26]
SNF1-T210A-HA MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
snf1::KAN [pSNF1-T210A-3HA (URA3)]
[26]
All strains are isogenic relative to BY4741.2.2. Protein extraction, immunoprecipitation assays and immunoblotting
Cells were collected by ﬁltration and immediately frozen at
−80 °C. Protein extractions, immunoprecipitations and western blot
analysis were performed essentially as described in [26]. For co-
immunoprecipation experiments, Swi6, Snf1-myc and RNA Pol II were
immunopuriﬁed from 1 to 5 mg of total protein extract. Anti-HA
mouse monoclonal antibody (12CA5, Roche), anti-myc mouse mono-
clonal antibody (9E10, Santa Cruz Biotechnology), anti-Swi6 rabbit
polyclonal antibody (kindly provided by L.L. Breeden), anti-pThr210
Snf1 rabbit polyclonal antibody (kindly provided by S. Hohmann),
anti-RNA Pol II (8WG16, Abcam) and anti-Pgk1 mouse monoclonal an-
tibody (Molecular Probes) (1:500 dilution for anti-myc; 1:1000 dilution
for all other antibodies) were used for western blot analysis.
2.3. Flow cytoﬂuorimetric analysis
Cells were collected, ﬁxed in 70% ethanol, stainedwith SYTOXGreen
nucleic acid stain (Molecular Probes) and analyzed for DNA content as
described in [26]. Flow cytoﬂuorimetric analysis was performed using
a BD FACScan (Becton-Dickinson).
2.4. RNA puriﬁcation and qReal-time PCR
Total RNA was isolated using a phenol-chloroform protocol, essen-
tially as previously described [26]. Reverse transcription of 0.5 μg of
mRNAs was carried out with iScript cDNA Synthesis Kit (BIO-RAD).
Quantitative Real-time PCR for CLN2, PCL1, CLB5 and RNR1 gene expres-
sion was performed using SsoFast EvaGreen Supermix (BIO-RAD),
oligos available upon request. Obtained data were normalized to both
PGK1 and CDC34 reference genes and organizedwith CFXmanager soft-
ware (BIO-RAD). Data are presented as the mean value ± standard de-
viation from at least three independent experiments performed in
triplicate.
2.5. Chromatin Immunoprecipitation and sequential chromatin
immunoprecipitation
Chromatin Immunoprecipitation was performed essentially as pre-
viously described in [55]. In a few instances the protocol was changed
as described afterward. Cells were grown and treatedwith 1% formalde-
hyde for 25 min. Glycine was added to a ﬁnal concentration of 375 mM
and the cultureswere further incubated for 5 min at room temperature.
Cells were then washed once with cold HBS buffer (50 mM Hepes
pH 7.5, 140 mM NaCl); after ﬁltration cell pellets were resuspended in
400 μl ChIP lysis buffer (50 mM Hepes pH 7.5, 140 mM NaCl, 1 mM
EDTA, 0.1% sodium deoxycholate, 1% Triton X-100, 1 mM PMSF, prote-
ases inhibitor mix Complete EDTA free Protease Inhibitor Cocktails Tab-
lets, Roche). The cell suspension was then mixed with an equal volume
of glass-beads and cells were broken at 4 °C on vortex. Cell lysates
were sonicated to yield an average DNA fragment size of 500 bp and
clariﬁed by centrifugation at 10,000 ×g for 15 min. Protein concentra-
tion for each sample was measured by the Bradford method using a
BIO-RAD protein assay kit. An equal amount of proteins (0.5–1 mg)
was incubated overnight at 4 °C with 5 μl of anti-myc mouse monoclo-
nal antibody (9E10, Santa Cruz Biotechnology), anti-HA mouse mono-
clonal antibody (12CA5, Roche), anti-Swi6 rabbit polyclonal antibody
(kindly provided by L.L. Breeden), anti-Spt16 antibody (kindly provided
by T. Formosa), anti-Rpb1 antibody (8WG16, Abcam) and 30 μl of pro-
tein A magnetic beads (Millipore) previously equilibrated in ChIP lysis
buffer. The beads-bound immunocomplexes were washed three times
with ChIP lysis buffer, twice with TBS (20 mM Tris–HCl pH 7.5,
150 mM NaCl) and once with TE (10 mM Tris–HCl pH 8.0, 1 mM
EDTA). Each wash was performed for 10 min at 4 °C. To detect Snf1-
myc at CLN2 and RNR1 genes a sequential ChIP was performed, starting
with a ChIP with anti-Rpb1 antibody (1st ChIP) followed by a ChIP
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the immunoprecipitatedmaterialwas eluted frommagnetic beads by in-
cubation at 65 °C for 10 min with 150 μl of TE containing 1% SDS. The
eluted material was then incubated at 65 °C for 6 h to reverse the
cross-link and the immunoprecipitated DNA was puriﬁed using a PCR
puriﬁcation kit (Qiagen) following the instructions of the manufacturer.
Control immunoprecipitations without anti-RNA Pol II antibody (no Ab)
or from a strainwithout tag (no tag) were also performed to subtract the
background. For the sequential ChIP assay, as a control for the ﬁrst ChIP
anti-Rpb1 antibodywas omitted in the no Ab control; for the secondChIP
in the no Ab control, anti-myc antibody was omitted. Real-time PCRs
were performed to quantify the relative enrichment of target DNA frag-
ments after immunoprecipitation with anti-myc, anti-HA or anti-RNA
Pol II antibody. Reactions were performed in triplicate using the Sso
Fast EvaGreen Supermix (BIO-RAD) and carried out in a MiniOpticon
(BIO-RAD). The enrichment of target regions were calculated using an
intergenic region of Chromosome I as a reference for nonspeciﬁc DNA,
as reported in [56]. For each experiment shown, ChIP analysis was
performed at least twice using independently prepared batches of chro-
matin. The results were compared by using a two-sided Student's t-test.
Differences were considered statistically signiﬁcant at p b 0.05.
2.6. Chemical synthesis
Synthesis and spectroscopic data of compound 2NM-PP1 are reported
in Supplementary information.
3. Results
3.1. Snf1 promotes transcription of G1-speciﬁc genes
Previous studies from our group have revealed a connection be-
tween protein kinase Snf1 and cell cycle control at the G1/S phase tran-
sition, since loss of Snf1 affects the proper expression of CLB5 gene [26].
To further investigate whether Snf1 could be involved in the regulation
of other G1-regulon genes, we extended our analyses to both SBF- and
MBF-dependent genes. As shown in Fig. S1A, SNF1 deletion reducedMBF-depen
SBF-depen
Fig 1. Snf1 deletion affects G1-gene transcription.wt and snf1Δ strainswere grown in synthetic
and released into freshmedium. Samples were taken at the indicated time points to assay CLN2
are the mean ± standard deviations of three independent experiments.growth rate in synthetic medium with 2% glucose as carbon source, as
previously reported [26], with about 43% of the population which
shows 1C DNA content (Supplementary Fig. S1B) and a reduced expres-
sion of G1-speciﬁc genes (Supplementary Fig. S1C).
To better investigate this phenotype in 2% glucose, snf1Δ cells
were synchronized by α-factor treatment and the expression of two
representative SBF-dependent genes (CLN2 and PCL1) and two MBF-
dependent ones (CLB5 and RNR1) was investigated. As shown in Fig. 1
the expression of those geneswas reducedmainly 20 min afterα-factor
release, coherently with the delayed S-phase entrance (previously re-
ported in [26]), indicating that Snf1 may be involved in the regulation
of both SBF- and MBF-dependent transcription.
The induction of G1-speciﬁc transcription requires the transcription
factor Swi6, which is tethered to promoters through its binding to Swi4
and Mbp1 [34,57]. Given that Snf1 interacts with Swi6 [26] also in cells
lacking the DNA-binding proteins Swi4 or Mbp1 (Fig. 2A), we exam-
ined, by ChIP experiments, whether Snf1 was able to affect the interac-
tion of SBF and MBF subunits to promoters of CLN2 and CLB5 genes in
G1-synchronized cells. In snf1Δ mutant, after α-factor release, Swi6
binding to CLN2 and CLB5 promoters was impaired, remaining low
and without any signiﬁcant increase at all analyzed time points
(Fig. 2B). On the contrary wild type cells showed an increase of Swi6
binding to CLN2 and CLB5 promoters 10–20 min after the release
(Fig. 2B), coherently with the maximum expression of the correspond-
ing mRNAs (Fig. 1).
It is well known that Swi6 interaction to promoters of G1-genes is
mediated by the DNA binding-proteins Swi4 and Mbp1 [36,58,59].
Since our data showed a defective Swi6 recruitment to promoters in
the snf1Δ strain, we investigated whether that alteration could reﬂect
a dysfunctional interaction of Swi4 and Mbp1 to DNA. We therefore
performed ChIP analyses in G1-synchronized cells in order to evaluate
the binding of Swi4 to SCB elements of CLN2 promoter and of Mbp1 to
MCB elements of CLB5 promoter. Our analyses showed that in the con-
trol culture, in-locus tagged Swi4-myc and Mbp1-HA proteins were re-
cruited to promoters and their binding increased and reached a
maximum10 min after theα-factor release (Fig. 2C and D). On the con-
trary, SNF1 deletion impaired the interaction of both Swi4-myc anddent genes
dent genes
medium containing 2% glucose until exponential phase, G1-arrested byα-factor treatment
, PCL1, CLB5 and RNR1mRNA level by quantitative relative Real-time PCR. Reported values
AB
Swi6
wt    swi4 mbp1 swi6
Swi6       +          +         +         -
IB α-Swi6 
IB α-Swi6 
IB α-Swi6 IB α-myc 
IB α-myc 
Snf1-myc       +          +         +         +
wt    swi4 mbp1 swi6
Swi6       +          +         +         -
Snf1-myc       +          +         +         +
**
**
**
* *
*
*
***
wt  snf1
IB α-Pgk1 
Swi6
Swi4 Mbp1
C D
wt  snf1
IB -myc
IB -Pgk1
Swi4-myc
wt  snf1
IB -HA
IB -Pgk1
Mbp1-HA
**
**
**
*
**
**
*
Fig. 2. Snf1 is required for the binding of SBF andMBF complexes to G1-promoters. (A) The strains wt, swi4Δ,mbp1Δ and swi6Δ expressing in-locus tagged Snf1-mycwere grown in syn-
thetic medium containing 2% glucose, the immunoprecipitations (IP) were performed with anti-myc antibody (left panel) or anti-Swi6 antibody (right panel) and analyzed by western
blot (IB)with anti-Swi6 antibody and anti-myc antibody. (B)wt and snf1Δ strainswere grown in syntheticmedium containing 2%glucose, G1-arrested byα-factor treatment and released.
Samples were collected at the indicated time points after the release to perform a Chromatin Immunoprecipitation (ChIP) analysis using anti-Swi6 antibody. (C–D) wt and snf1Δ strains
expressing in-locus tagged Swi4-myc (C) orMbp1-HA (D)were grown in syntheticmedium containing 2% glucose, synchronized inG1-phase byα-factor treatment and released. Samples
were collected at the indicated time points after the release to perform ChIP analysis using anti-myc or anti-HA antibodies. (B–D) Speciﬁc regions of CLN2 and CLB5 genes promoter
containing SCB or MCB elements were ampliﬁed. The amount of immunoprecipitated DNA was normalized to a non-transcribed region of Chromosome I sequence present in the IP
DNA and in consideration of the input DNA. Relative quantiﬁcation was performed with respect to a no tag strain control, which was set as 1. *p b 0.05, **p b 0.005. Reported values
are the mean ± standard deviations of at least two independent experiments. Insets show the amount of Swi6-myc, Swi4-myc and Mbp1-HA proteins in wt and snf1Δ strains, analyzed
by western blot with anti-myc or anti-HA antibody. Pgk1 was used as a loading control.
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level (Fig. 2C and D).
Taken together, theseﬁndings support the notion that the binding of
SBF and MBF components to G1-promoters is lower in snf1Δ cells.
3.2. Snf1 is required to recruit FACT complex and RNA PoI II to G1-gene
promoters
The binding of SBF andMBF complexes to DNA sets the stage for the
interaction of co-activators, including the FACT complex, which regulatechromatin remodeling to guarantee transcriptional initiation [46,47].
The co-activators, then, promote the binding of RNA Pol II to DNA, an
event which determines the formation of a Pre-Initiation Complex
(PIC) required for transcription initiation [43–45,47].
Since our data indicate that SNF1 deletion is consistent with a
reduction of SBF and MBF binding to CLN2 and CLB5 promoters, we
investigated whether this effect could inﬂuence the formation of
the Pre-Initiation Complex. For this reason, we analyzed the binding
of the FACT complex and of RNA Pol II to G1-speciﬁc gene promoters.
Wild type and snf1Δ strains were synchronized in G1 phase byα-factor
3258 S. Busnelli et al. / Biochimica et Biophysica Acta 1833 (2013) 3254–3264treatment and released into fresh medium. Then, a ChIP assay was
performed using an antibody speciﬁc for Spt16 (a component of
FACT complex) or for Rpb1 protein (the large subunit of RNA Pol II
complex). Immunopuriﬁed DNA was analyzed by Real-time PCR
using primers which amplify TATA box sequences of CLN2, PCL1,
CLB5 and RNR1 promoters. ChIP analyses performed in the control
strain showed, as expected, a peak of the FACT binding at promoters
20 min after the release from α-factor arrest (Fig. 3A). On the con-
trary, in the snf1Δ strain no peak of Spt16 recruitment was observed
at any analyzed promoter (Fig. 3A). In keeping with those data, also
the association of RNA Pol II to the same promoters was impaired
in the snf1Δ mutant (Fig. 3B).
Therefore, our ﬁndings indicate that the formation of the Pre-
Initiation Complex, which is required for the transcription initiation of
G1-speciﬁc genes, is affected in cells lacking SNF1.A Spt1
RpbB
SBF-depend
SBF-depend
MBF-depend
**
**
MBF-depend
** **
**
**
Fig. 3. Snf1 is required for RNA Pol II and FACT complex recruitment to SBF- andMBF-dependen
α-factor treatment and released into freshmedium. Samples were taken at the indicated time p
Rpb1 antibody (8WG16). Relative Spt16 (A) or Rpb1 (B) occupancy at the TATA boxofCLN2, PCL
which was set as 1. Reported values are the mean ± standard deviations of two independen
*p b 0.05, **p b 0.005.3.3. Snf1 kinase activity is required for the transcription of G1-speciﬁc genes
Since our data indicate a function of Snf1 in cells grown in not limit-
ing glucose conditions (2% glucose), we analyzed whether that role
might depend on its kinase activity. First of all, a slight phosphorylation
of Thr210 residue of Snf1 was detectable in 2% glucose, suggesting that
in this condition Snf1 kinase was partially catalytically active (Fig. 4A),
consistent with previous reported data [60,61]. Then, to investigate
the function of Snf1 kinase activity on the expression of cell cycle
genes, we used a strain expressing a non-phosphorylatable form of
Snf1 (Snf1-T210A), which cannot be activated by phosphorylation on
the T-loop Thr210 residue [62]. As previously reported [26], this strain
shows a delay of S-phase entrance, although to a lesser extent than a
snf1Δ strain. Coherently, the expression of SBF- and MBF-dependent
genes was reduced mainly 20 min after α-factor release (Fig. 4B).6
1
ent genes
ent genes
ent genes
** *
**
**
ent genes
**
**
**
**
t promoters. (A–B)wt and snf1Δ strains were grown in exponential phase, G1-arrested by
oints to perform Chromatin Immunoprecipitation assay using anti-Spt16 antibody or anti-
1,CLB5 andRNR1 geneswas setwith respect to occupancy ofwild type strain at time 0 min,
t experiments, all data were normalized to a non-transcribed region of Chromosome I.
AB
MBF-dependent genes
SBF-dependent genes
IP -HA
IB -pThr210 Snf1
IB α-HA 
Snf1-HA
Fig. 4. Snf1 is phosphorylated on residue T210 in 2% glucose growing cells. (A) A Snf1-HA expressing strainwas grown in syntheticmedium containing 2% glucose until exponential phase,
then a part of the culture was ﬁltered, washed and shifted into synthetic medium containing 0.05% glucose for 10 min (0.05%). The rest of the culture was synchronized in G1 phase byα-
factor treatment, released into fresh medium and samples were taken at different time points (0, 20, 30, 40, 70 min). Snf1-HA was immunoprecipitated (IP) with anti-HA antibody and
analyzed bywestern blot (IB)with anti-pT210 Snf1 antibody or anti-HA antibody. As a control of antibody speciﬁcity, Snf1 was immunoprecipitated from a strain expressing Snf1-T210A-
HA. (B) Strains expressing Snf1 wt or Snf1-T210A were grown in synthetic medium containing 2% glucose until exponential phase, G1-arrested by α-factor treatment and released into
freshmedium. Samples were taken at the indicated time points to assay CLN2, PCL1, CLB5 and RNR1mRNA level by quantitative relative Real-time PCR. Reported values are the mean ±
standard deviations of three independent experiments.
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completely abolish Snf1 activity [15,16,18] we used a strain expressing
an analog-sensitive (as) allele of SNF1, SNF1as(I132G) encoding a pro-
tein whose catalytic activity is selectively inhibited in vivo by 2-
naphthylmethyl pyrazolopyrimidine 1 (2NM-PP1) [53].
Treatment with 2NM-PP1 reduced the growth rate of exponen-
tially growing SNF1as cells, determining an increase of cells with
1C DNA content, already detectable 60 min after the treatment
(Supplementary Fig. S2), rendering the SNF1as strain very similar to
a snf1Δ strain (compare Supplementary Fig. S2 with Supplementary
Fig. S1).
Then, to investigate this effect on a synchronous population, expo-
nentially growing SNF1as cells were synchronized with α-factor, after
1 h the culture was treated with 25 μM 2NM-PP1 for an additional
hour and then released into fresh medium containing 25 μM 2NM-
PP1. In the absence of the inhibitor, in accordance with the onset of
bud emergence and DNA replication, the SNF1as strain expressed G1-
speciﬁc genes as the wild type (Fig. 5A–C). Remarkably, the addition
of 2NM-PP1 delayed S-phase entrance by affecting the expression of
both SBF- and MBF-dependent genes (Fig. 5A–C) as well as the associa-
tion of Rpb1 to CLN2, PCL1, CLB5 and RNR1 promoters (Fig. 5D). As
expected, treatment with 2NM-PP1 on SNF1wt cells had no effect onbudding index, DNA content and G1-gene expression (Supplementary
Fig. S3), conﬁrming the speciﬁcity of 2NM-PP1.
To exclude any artefacts due to the use of α-factor in our experi-
ment, centrifugal elutriation was chosen as a different method of G1
synchronization. After release in fresh pre-warmed medium, G1 elutri-
ated snf1Δ cells remained mostly unbudded until 240 min, indicating
that loss of Snf1 causes a severe delay in the beginning of a new cell
cycle (Supplementary Fig. S4). Nevertheless, since it is well known
that centrifugation activates Snf1 [21], we decided to overcome any
problem due to centrifugation in a snf1Δ background making the
same experiment on SNF1as cells. SNF1as cells were grown in synthetic
medium with 2% glucose until late exponential phase and elutriated to
obtain cells in G1 phase in the absence of the inhibitor, to ensure that
cells with an active Snf1 protein could respond to the g stress of centri-
fugation. Small unbudded cells were then re-inoculated in fresh pre-
warmed medium at time 0 with 0.1% DMSO (solvent control) or with
2NM-PP1 to inhibit Snf1 activity. As reported in Fig. 6, treatment with
the inhibitor severely impaired budding, DNA replication, as well as
the expression of CLN2 and RNR1 mRNA (Fig. 6A–C), with an increase
of CLN2 expression only 135 min after the release (Fig. 6C).
Taken together our results strongly support the notion that the cat-
alytic activity of Snf1 is required to promote G1-transcription.
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3260 S. Busnelli et al. / Biochimica et Biophysica Acta 1833 (2013) 3254–32643.4. Snf1 is recruited to both SBF and MBF-regulated promoters
Since Snf1 modulates the recruitment of RNA Pol II to promoters, a
physical interaction of Snf1 with RNA Pol II was investigated. We
found that Snf1 was detected in Rpb1 immune complexes 20 min
after α-factor release (Fig. 7A).
We reasoned therefore that Snf1 itself could be directly recruited to
the promoters, together with RNA Pol II. Since it has recently been re-
ported that Snf1 is detectable at the promoter of ADY2 by a sequentialChIP approach [63], we performed a sequential ChIP experiment using
an initial ChIP with anti-Rpb1 antibody and then a second re-ChIP
with anti-myc antibody to enrich for chromatin bound to Snf1. A strain
expressing an in-locus tagged Snf1-myc proteinwas synchronized in G1
phase by α-factor treatment and released into fresh medium; samples
were collected at times 0 and 20 min after the release for sequential
ChIP experiments (considering that the maximum recruitment of RNA
Pol II to promoters was detected at 20 min, as shown in Fig. 3B).
Immunopuriﬁed DNA was analyzed by Real-time PCR using primers
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CLN2 and RNR1 genes (Int. 1 and Int. 2, amplicon positions shown in
Fig. 7B and C). Both CLN2 and RNR1promoter sequenceswere speciﬁcal-
ly detected in association with Snf1-myc 20 min after the release from
G1 arrest (Fig. 7B and C, compare the increase of signal between the
ﬁrst and the second ChIP in Snf1-myc cells vs no tag control). Further-
more, capture of Snf1-myc speciﬁcally recovered also DNA fragments
of internal coding regions of both genes (Fig. 7B and C). No association
of Snf1-myc was detected at CDC34 gene (Supplementary Fig. S5),
supporting the speciﬁcity of the presence of Snf1 at SBF- and MBF-
dependent genes.
Collectively these data indicate that the catalytic activity of Snf1
modulates G1-speciﬁc transcription by promoting the interaction of
RNA Pol II to SBF- and MBF-regulated genes.
4. Discussion
Accurate and regulated transcription of eukaryotic genes represents
a major step in gene regulation, requiring the coordinated activity of a
large number of proteins and protein complexes. It is well known that
Snf1, the master regulator of cellular energy balance [64], regulates
transcription of various metabolic genes acting at different levels,
including regulation of transcription factors [65–67], modulation of
Chromatin remodeling process [25,63,68,69] and interaction with the
Srb/mediator complex of RNA polymerase II holoenzyme [19].
Building upon previous results from our laboratory, which indicated
that Snf1 positively regulates yeast cell cycle progression in cells grow-
ing in 2% glucose [26], we newly report in this paper a direct involve-
ment of Snf1 catalytic activity in modulating different aspects of
transcription at the G1-regulon. Indeed the mutant SNF1as treated
with the inhibitor 2NM-PP1 shows a reduced recruitment of RNA Pol
II to G1 promoters and, as a consequence, a reduced transcription of
G1-regulon which leads to a delayed S-phase entrance (Fig. 5–6). Nota-
bly, the binding of Swi6, Swi4 andMbp1 to SCB andMCB elements is af-
fected in the absence of Snf1 (Fig. 2) and Snf1 protein is detectable not
only at the TATA boxes of SBF- and MBF-dependent promoters but
also at the internal coding regions of the same genes (Fig. 7A–C),conﬁrming the requirement of Snf1 activity for G1 transcription. More-
over, also the SNF1-T210A mutant has an impaired expression of G1-
speciﬁc genes (Fig. 4B), although to a lesser extent than the snf1Δ strain.
Consistently, we previously reported that while the SNF1-T210Amutant
shows a cell-cycle defect in 2% glucose and a delayed S-phase entrance,
the SNF1-T210Emutant is almost undistinguishable from the wild type
strain [26], suggesting a constitutive phosphorylation of Snf1 on T210
in 2% glucose, as we show in the present paper (Fig. 4A). The fact that
Snf1 is weakly phosphorylated also in 2% glucose conﬁrms that it can
be partially active in that growth condition. In keeping with our results
there are multiple lines of evidence indicating regulatory roles for Snf1
basal kinase activity in the presence of glucose. In fact, previous studies
showed that a low level of Snf1 activity is sufﬁcient and essential to
confer resistance to different stress conditions such as toxic cations,
hydroxyurea and heat shock also in glucose growing cells [15,24,70].
Furthermore, it has also been reported that Snf1 stimulates Gcn2
kinase activity during histidine starvation of glucose grown-cells [71],
reinforcing the notion of a quantitative regulation of Snf1 kinase
activity.
Although the general observation is that the absence of Snf1 causes
little or no perturbations of cells growing in complete medium (YPD,
with 2% glucose), we highlight that SNF1 deletion reduces growth rate
in synthetic medium with 2% glucose, increases the percentage of cells
with 1C DNA content and reduces the expression of G1-speciﬁc genes
(Supplementary Fig. S1). By using the SNF1as mutant we also show
that treatment with 2NM-PP1 reduces the growth rate of exponentially
growing SNF1as cells, determining an increase of cells with 1C DNA con-
tent (Supplementary Fig. S2), rendering the SNF1as mutant very similar
to a snf1Δ strain and indicating that the kinase activity of Snf1 is impor-
tant for cell growth also in non-synchronized cells. This phenotype is
fully complemented in 5% glucose [26]. Our data therefore indicate a
new function of Snf1 in glucose growing cells, although we believe
that additional work is required to better elucidate that role.
One question that still needs to be answered is which are the sub-
strates of Snf1 involved in G1-transcription. Remarkably, although
Swi6 is phosphorylated by Snf1 in vitro on Ser760, site-speciﬁc mutants
(SWI6-S760A or SWI6-S760E) show neither an alteration of growth rate
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3262 S. Busnelli et al. / Biochimica et Biophysica Acta 1833 (2013) 3254–3264nor relevant defects in S-phase entrance (Supplementary Fig. S6), sug-
gesting that Snf1 could stimulate gene expression by phosphorylating
different key proteins, acting at several levels of the transcriptional pro-
cess under physiological conditions. Notably, Snf1 is known tomodulate
the acetylation of histones at different genes [63,72] and a recent work
has also suggested a possible role of this kinase on the activity of RNA
Pol II complex [19]. Therefore, althoughwe found Snf1 in immune com-
plexes of Rpb1,we donot completely exclude an indirect interaction be-
tween Snf1 and RNA Pol II mediated by other components of the
transcription apparatus.
As summarized in Fig. 8, novel ﬁndings obtained in this paper show
that Snf1 plays a relevant role in regulating the G1/S transition by (i)
promoting the binding of Swi4, Mbp1 and Swi6 proteins to SCB and
MCBelements of G1 promoters and consequently (ii) favoring the prop-
er recruitment of the FACT complex and RNA Pol II, which are required
for both transcription initiation and elongation at the same genes; (iii)
moreover our evidences show that Snf1 interacts with promoters andcoding regions of G1-genes, thus a possible involvement in the elonga-
tion process can also be suggested.
Until now, the importance of Snf1/AMPK has been limited to its role
as a regulator of cellularmetabolism. However, a link betweenmetabol-
ic regulation and cell cycle control is required in order to ensure that cell
division occurs only if the energy status of the cell is able to support it.
Several data suggest the existence of such a link in higher eukaryotes,
but this regulation appears to be complex. Literature data indicate that
in mammalian cells the activation of AMPK correlates with the arrest
of cell cycle in G1 phase [73,74]. On the other hand, studies inDrosophila
andmammalian cells have demonstrated that the role of AMPK in ener-
gy sensing is coupled with essential cell biology functions, such as cell
polarity and cell division [75]. AMPK also regulates mitotic progression
in mammalian cells, independently from a low cellular energy status
[76,77] and data from Arabidopsis thaliana indicate a function for Snf1-
related protein kinases KIN10/KIN11 in normal vegetative and repro-
ductive growth [78].
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3263S. Busnelli et al. / Biochimica et Biophysica Acta 1833 (2013) 3254–3264Thus, our novel results, which show a role for Snf1 in the regulation
of cell cycle in not-limiting glucose conditions, indicate that in the bud-
ding yeast, as in higher eukaryotes, apart from the regulation of cellular
processes in response to energy stresses, the conserved Snf1/AMPK
family can coordinate essential and basic cellular functions under phys-
iological conditions as well.
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